Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support

NCT04429334 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID19

Interventions

DRUG: nangibotide
DRUG: placebo

Sponsor

Inotrem